Status:
TERMINATED
Should Graf IIc Hips be Treated for 12 Weeks
Lead Sponsor:
University of Colorado, Denver
Conditions:
Developmental Dysplasia of Hip
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
Children who are diagnosed with Developmental Hip Dysplasia (DDH) are often categorized depending on the severity of their hip malformation. Regardless of the severity, the accepted form of treatment ...
Detailed Description
Developmental Dysplasia of the Hip is a thoroughly researched and manageable disease if treated correctly. While the literature agrees that Pavlik Harness treatment is the best means of treatment, the...
Eligibility Criteria
Inclusion
- 1\. Patients with:
- DDH
- Graf IIc hips (alpha angle = 43-49 degrees)
- normal hip exam (stable hips)
- abnormal ultrasound
Exclusion
- Patients with additional conditions: Neurologic or teratologic.
- Follow up that occurs at any other institution.
- Unstable hips
Key Trial Info
Start Date :
June 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03275805
Start Date
June 11 2021
End Date
July 1 2025
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045